Market Cap 150.69M
Revenue (ttm) 134.86M
Net Income (ttm) 2.35M
EPS (ttm) N/A
PE Ratio 26.39
Forward PE 63.90
Profit Margin 1.74%
Debt to Equity Ratio 0.52
Volume 302,500
Avg Vol 198,662
Day's Range N/A - N/A
Shares Out 21.02M
Stochastic %K 100%
Beta 1.81
Analysts Strong Sell
Price Target $13.30

Company Profile

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 248 291 1210
Fax: 800 455 4338
Address:
3851 West Hamlin Road, Rochester Hills, United States
StockScanners
StockScanners Aug. 7 at 1:16 AM
$INFU keep watch if this holds above 6.80
0 · Reply
StockBraker
StockBraker Aug. 6 at 10:29 PM
$INFU This is why we are seeing such good results today. Matt and Kyle's 12 mo PTs have lifted the consensus to $13. Expect a slow, steady increase over the coming weeks.
0 · Reply
StudBull
StudBull Aug. 5 at 2:01 PM
$INFU huge improvement in profitability that should accelerate after completion of software upgrade in Q1 2026
0 · Reply
StockBraker
StockBraker Aug. 5 at 12:24 PM
$INFU Blowout quarter
1 · Reply
StudBull
StudBull Jul. 31 at 4:03 PM
$INFU Currently trading around 1X EV/Revenue and 5.1X EV/EBITDA, well below industry comps. What am I missing? Anyone have any thoughts?
1 · Reply
StudBull
StudBull Jul. 23 at 10:51 PM
$INFU new analyst coverage
0 · Reply
Ka1ch123
Ka1ch123 Jul. 23 at 9:43 AM
$INFU if I can get in @ 5.40 - 5.60. this has serious potential
0 · Reply
Awooga
Awooga Jul. 18 at 7:22 PM
$INFU a good time to get in
1 · Reply
StudBull
StudBull Jul. 17 at 7:02 PM
$INFU This stock seems way too cheap at 5.1X EV/EBITDA and 1.0X EV/Sales. Company is expected to grow +8-10% this year with 18-20% EBITDA margins, low debt, little/no tariff exposure, and stock buybacks
2 · Reply
StudBull
StudBull Jun. 22 at 12:05 PM
$INFU https://seekingalpha.com/article/4796335-infusystem-investments-starting-to-pay-off
0 · Reply
Latest News on INFU
InfuSystem Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 6:30 AM EDT - 2 days ago

InfuSystem Reports Second Quarter 2025 Financial Results


InfuSystem: Investments Are Starting To Pay Off

Jun 22, 2025, 1:30 AM EDT - 6 weeks ago

InfuSystem: Investments Are Starting To Pay Off


InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript

May 10, 2025, 12:06 PM EDT - 3 months ago

InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript


InfuSystem Reports First Quarter 2025 Financial Results

May 8, 2025, 6:30 AM EDT - 3 months ago

InfuSystem Reports First Quarter 2025 Financial Results


InfuSystem Set For Strong Year

Feb 10, 2025, 9:21 AM EST - 6 months ago

InfuSystem Set For Strong Year


InfuSystem Appoints Ronald Hundzinski to the Board of Directors

Nov 18, 2024, 9:15 AM EST - 9 months ago

InfuSystem Appoints Ronald Hundzinski to the Board of Directors


InfuSystem Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 6:30 AM EST - 9 months ago

InfuSystem Reports Third Quarter 2024 Financial Results


InfuSystem Set For Strong Second Half

Aug 26, 2024, 9:03 AM EDT - 1 year ago

InfuSystem Set For Strong Second Half


InfuSystem Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 6:30 AM EDT - 1 year ago

InfuSystem Reports Second Quarter 2024 Financial Results


InfuSystem Announces $20 Million Stock Repurchase Program

May 20, 2024, 4:30 PM EDT - 1 year ago

InfuSystem Announces $20 Million Stock Repurchase Program


InfuSystem Reports First Quarter 2024 Financial Results

May 9, 2024, 6:30 AM EDT - 1 year ago

InfuSystem Reports First Quarter 2024 Financial Results


InfuSystem Holdings: 2024 Will Be A Year Of Monetization

Feb 28, 2024, 11:48 PM EST - 1 year ago

InfuSystem Holdings: 2024 Will Be A Year Of Monetization


InfuSystem Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 6:30 AM EST - 1 year ago

InfuSystem Reports Third Quarter 2023 Financial Results


InfuSystem Reports Second Quarter 2023 Financial Results

Aug 3, 2023, 6:30 AM EDT - 2 years ago

InfuSystem Reports Second Quarter 2023 Financial Results


InfuSystem Set to Join Russell 3000® Index

Jun 21, 2023, 6:30 AM EDT - 2 years ago

InfuSystem Set to Join Russell 3000® Index


InfuSystem Reports First Quarter 2023 Financial Results

May 4, 2023, 6:30 AM EDT - 2 years ago

InfuSystem Reports First Quarter 2023 Financial Results


StockScanners
StockScanners Aug. 7 at 1:16 AM
$INFU keep watch if this holds above 6.80
0 · Reply
StockBraker
StockBraker Aug. 6 at 10:29 PM
$INFU This is why we are seeing such good results today. Matt and Kyle's 12 mo PTs have lifted the consensus to $13. Expect a slow, steady increase over the coming weeks.
0 · Reply
StudBull
StudBull Aug. 5 at 2:01 PM
$INFU huge improvement in profitability that should accelerate after completion of software upgrade in Q1 2026
0 · Reply
StockBraker
StockBraker Aug. 5 at 12:24 PM
$INFU Blowout quarter
1 · Reply
StudBull
StudBull Jul. 31 at 4:03 PM
$INFU Currently trading around 1X EV/Revenue and 5.1X EV/EBITDA, well below industry comps. What am I missing? Anyone have any thoughts?
1 · Reply
StudBull
StudBull Jul. 23 at 10:51 PM
$INFU new analyst coverage
0 · Reply
Ka1ch123
Ka1ch123 Jul. 23 at 9:43 AM
$INFU if I can get in @ 5.40 - 5.60. this has serious potential
0 · Reply
Awooga
Awooga Jul. 18 at 7:22 PM
$INFU a good time to get in
1 · Reply
StudBull
StudBull Jul. 17 at 7:02 PM
$INFU This stock seems way too cheap at 5.1X EV/EBITDA and 1.0X EV/Sales. Company is expected to grow +8-10% this year with 18-20% EBITDA margins, low debt, little/no tariff exposure, and stock buybacks
2 · Reply
StudBull
StudBull Jun. 22 at 12:05 PM
$INFU https://seekingalpha.com/article/4796335-infusystem-investments-starting-to-pay-off
0 · Reply
StudBull
StudBull Jun. 17 at 11:10 PM
$INFU This stock is trading at 1.1X EV/Rev and 5.9X EV/EBITDA which seems way too cheap for a company expected to grow 8-10%+ this year with 18 - 20%+ EBITDA margins
0 · Reply
Bigeyes2
Bigeyes2 Jun. 14 at 6:00 PM
$INFU an inverted head and shoulders
0 · Reply
StudBull
StudBull May. 29 at 1:03 PM
$INFU Company will present at Sidoti Small-Cap Virtual Investor Conference on June 11th and 12th New Form 4 filings show two Directors buying stock in open market purchases, following buys by new CEO and CFO
0 · Reply
StudBull
StudBull May. 27 at 4:57 PM
$INFU stock is trading at 6.8X trailing EV/EBITDA, and 5.14X forward EV/EBITDA. The company is expected to continue growing +8 - 10%, with continued margin expansion. Management confirmed on the recent Q1 earnings call (double beat) that they have little (if any) tariff exposure, and little (if any) exposure to government spending cuts. The company has also been buying back stock, with management recently buying stock as well. The sell off in this stock seems full retard
1 · Reply
StudBull
StudBull May. 19 at 1:48 PM
$INFU New Form 4 filing. CEO buying stock
0 · Reply
StudBull
StudBull May. 15 at 1:48 PM
$INFU New Form 4 filing. Nice to see the CFO buying stock
0 · Reply
StudBull
StudBull May. 13 at 12:39 PM
$INFU New presentation slides: https://d1io3yog0oux5.cloudfront.net/_1fd52e9df9adf8d776aa62d8d1f9b71e/infu/db/164/2912/pdf/Exhibit+99.1+1Q25Investor+Presentation.pdf
0 · Reply
StudBull
StudBull May. 8 at 6:43 PM
$INFU Q1 2025 results crushed street estimates
0 · Reply
StockBraker
StockBraker May. 8 at 11:44 AM
1 · Reply
StudBull
StudBull Apr. 3 at 4:01 PM
$INFU I think CEO is departure is a major upgrade, and overdue
1 · Reply
StudBull
StudBull Apr. 1 at 2:22 PM
$INFU Expected 8-10% growth and continued margin expansion, with multiple growth options and demographic tailwinds. What am I missing?
0 · Reply
DonCorleone77
DonCorleone77 Apr. 1 at 10:42 AM
$INFU InfuSystem still sees 2025 revenue growth 8%-10% from $134.86M in 2024 Consensus for 2025 revenue is $146.48M. Sees 2025 adjusted EBITDA margin in the high teens, exceeding the company's margin of 18.8% in 2024.
0 · Reply